Application of arginine ethyl ester and / or lipoic acid in promoting depolymerization of aggregate in cell culture fluid

By using ethyl arginine and lipoic acid in cell culture medium to promote the depolymerization of macromolecular aggregates, the problem of removing impurities in extracellular vesicle fluid is solved, the purity and separation efficiency of extracellular vesicles are improved, and the Low-cost, efficient extracellular vesicle purification.

CN118995560APending Publication Date: 2024-11-22BEIJING ECHO PHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411172909.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-26
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The prior art is difficult to effectively remove impurities such as proteins and nucleic acids in the extracellular vesicle fluid, affecting the purity of extracellular vesicles and clinical use effect.

Method used

The arginine ethyl ester and/or lipoic acid are used to promote the depolymerization of macromolecular aggregates in cell culture medium, and the separation is carried out by tangential flow ultrafiltration or molecular sieve to remove impurities and improve the purity of extracellular vesicles.

Benefits of technology

It significantly reduces the content of heteroproteins and nucleic acids, improves the purity and separation efficiency of extracellular vesicles, reduces production costs, and is suitable for large-scale production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995560A_ABST
    Figure CN118995560A_ABST
Patent Text Reader

Abstract

The invention relates to application of arginine ethyl ester, a salt or a solvent compound thereof, and / or lipoic acid, a salt or a solvent compound thereof in promoting depolymerization of aggregates in a cell culture fluid. According to the method, substances capable of promoting depolymerization of macromolecular aggregates in the cell culture fluid are excavated, removal of the aggregates is facilitated, meanwhile, a pretreatment method capable of being applied to separation and purification of extracellular vesicles is further developed, depolymers such as arginine ethyl ester and / or lipoic acid are / is used in the aggregate depolymerization process, and separation and purification of the extracellular vesicles are facilitated. The device is used for opening large-molecular-weight aggregates in feed liquid, removal of non-extracellular vesicle products in the feed liquid is facilitated, and the purity of downstream separated and purified extracellular vesicles is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology and relates to the application of arginine ethyl ester and / or lipoic acid in promoting the disaggregation of aggregates in cell culture fluid. Background Art

[0002] Prokaryotic or eukaryotic cells synthesize and secrete a new type of cell communication - extracellular vesicles (EVs). According to the particle size, biological characteristics and synthesis pathway, EVs are divided into three types: ① exosomes: particle size 30-150nm; ② microvesicles: particle size 100-1000nm; ③ apoptotic bodies: particle size greater than 1000nm. Extracellular vesicles have a lipid bilayer structure similar to that of cells and play important biological roles: ① They carry out intercellular communication and perform various physiological or pathological functions, playing an important role in immune response, viral infection, pregnancy, cardiovascular disease, neurodegenerative diseases, and cancer; ② As an indicator of disease diagnosis: the proteins, lipids, nucleic acids, metabolites and other components contained in exosomes can be used as markers for cancer diagnosis and prognosis; ③ They are used for disease prevention and treatment, such as extracellular vesicles derived from mesenchymal stem cells (MSCs) have biological functions of immune regulation and damage repair; ④ As a drug delivery carrier for disease treatment, such as delivering drug proteins, nucleic acids, small molecules, etc.

[0003] In order to realize the functions and applications of the above-mentioned extracellular vesicles, it is necessary to extract, enrich, separate and purify EVs from various tissues, cells and body fluids to obtain target extracellular vesicles of appropriate purity. The preparation methods of extracellular vesicles (such as exosomes) mainly include fractional centrifugation (ultracentrifugation, density gradient centrifugation), polyethylene glycol precipitation, ultrafiltration, affinity chromatography (immunoaffinity chromatography and phosphatidylserine affinity chromatography), size exclusion chromatography (molecular sieve) and ion exchange chromatography. At present, any single method of exosome separation and purification cannot simultaneously meet the requirements of high purity, low cost, high recovery rate and large-scale production. The combination of processes with different separation or treatment principles is an effective way to obtain high-purity and high-yield extracellular vesicles.

[0004] When using the above method to separate and purify extracellular vesicles, it is necessary to pre-treat the feed solution or cell supernatant containing extracellular vesicles, such as removing cells or cell fragments and larger particles in the feed solution by centrifugation or filtration; adding nuclease to hydrolyze and remove free nucleic acid fragments in the feed solution. The feed solution also contains some biomacromolecule aggregates, forming nano-scale particles, which have similar physical and chemical properties to extracellular vesicles, affecting the downstream separation efficiency and the purity of extracellular vesicles. For example, current research on extracellular vesicles has found that cells secrete some protein aggregates with a diameter of 30 to 50 nm: exomere and supermere; at the same time, cells will secrete stress granules and other nucleic acid protein polymers (particle size is 0.1 to 2 μm) under various stress conditions. These protein polymers with a size close to that of extracellular vesicle particles are difficult to remove, which reduces the purity of extracellular vesicles and affects the clinical use of extracellular vesicles. At present, there is no effective solution for the removal of these protein aggregates.

[0005] In summary, in the process of preparing extracellular vesicles, cells must first be cultured to obtain a feed solution containing extracellular vesicles, and then extraction, separation, purification and other treatments must be performed. Secretions such as nucleic acids, proteins, and lipids in the feed solution will form large aggregates with a similar nanoscale to extracellular vesicles, making them difficult to separate. Therefore, there is an urgent need to develop methods that can effectively remove impurities such as proteins and nucleic acids from the feed solution of extracellular vesicles. Summary of the invention

[0006] In view of the deficiencies of the prior art and actual needs, the present invention provides the use of arginine ethyl ester (ArgEE) and / or lipoic acid (LA) in promoting the disaggregation of aggregates in cell culture fluid, explores substances that promote the disaggregation of aggregates in cell culture fluid, and expects to apply them to the field of removing impurities such as proteins and nucleic acids in the feed solution of extracellular vesicles.

[0007] To achieve this object, the present invention adopts the following technical solutions:

[0008] In a first aspect, the present invention provides use of arginine ethyl ester, a salt or a solvent compound thereof, and / or lipoic acid, a salt or a solvent compound thereof in promoting the disaggregation of aggregates in a cell culture medium.

[0009] In the present invention, substances that can promote the disaggregation of macromolecular aggregates in cell culture fluid are excavated. These substances can promote opening and dispersion to form monomers or smaller particles and polymers, which are convenient for separation based on molecular size through tangential flow ultrafiltration (TFF) or molecular sieve (exclusion chromatography), etc., to remove these aggregates. It has broad application prospects and can be widely used in fields that require separation and removal of macromolecular polymers in cell culture fluid, such as the field of separation and purification of extracellular vesicles from cell culture fluid.

[0010] The structural formula of arginine ethyl ester is shown in Formula I, and the structural formula of lipoic acid is shown in Formula II.

[0011]

[0012] Preferably, the aggregates comprise protein and / or nucleic acid aggregates.

[0013] Preferably, the cell culture fluid comprises a cell culture fluid containing extracellular vesicles.

[0014] In a second aspect, the present invention provides the use of arginine ethyl ester, its salt or solvent compound, and / or lipoic acid, its salt or solvent compound in the preparation of an agent for promoting the disaggregation of aggregates in a cell culture medium.

[0015] In a third aspect, the present invention provides a kit for promoting the disaggregation of aggregates in a cell culture medium, wherein the kit contains arginine ethyl ester, a salt or a solvent compound thereof, and / or lipoic acid, a salt or a solvent compound thereof.

[0016] In a fourth aspect, the present invention provides a method for pretreating a cell culture fluid containing extracellular vesicles, the pretreatment method comprising:

[0017] Arginine ethyl ester, its salt or solvent compound, and / or lipoic acid, its salt or solvent compound are added to the cell culture fluid containing extracellular vesicles, and separation operations such as ultrafiltration and molecular sieve are performed.

[0018] The present invention further develops a method applicable to the field of extracellular vesicle separation and purification, which effectively removes macromolecular aggregates in the extracellular vesicle feed solution, significantly reduces the content of foreign proteins and nucleic acids, and improves the efficiency and purity of downstream purification.

[0019] Preferably, the working concentration of arginine ethyl ester, its salt or solvent compound is 0.1-2 mol / L, including but not limited to 0.2, 0.3, 0.5, 0.8, 1, 1.2, 1.5, 1.6, 1.7, 1.8 or 1.9 mol / L, etc., preferably 0.25-1 mol / L.

[0020] Preferably, the working concentration of lipoic acid, its salt or solvent compound is 1-50mmol / L, including but not limited to 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 26, 27, 28, 29, 30, 35, 40, 45, 48 or 49mmol / L, etc., preferably 10-30mmol / L.

[0021] Preferably, the ultrafiltration comprises tangential flow ultrafiltration.

[0022] Preferably, the separation cut-off size is greater than 300 kDa, preferably 500-750 kDa.

[0023] Preferably, the cell culture fluid containing extracellular vesicles also includes an ultrafiltration and concentration step before pretreatment, specifically including: centrifuging the cell culture supernatant at 400-600×g and 3500-4500×g to remove cells and cell debris, then filtering with a membrane and concentrating by ultrafiltration for 3-5 times, and washing with phosphate buffer for 5-8 times as a starting sample.

[0024] Preferably, the pretreatment method may further include the step of adding nuclease.

[0025] As a preferred technical solution, the pretreatment method includes:

[0026] 0.1-2 mol / L of arginine ethyl ester, its salt or solvent compound, and / or 1-50 mmol / L of lipoic acid, its salt or solvent compound are added to the cell culture fluid containing extracellular vesicles, and tangential flow ultrafiltration or molecular sieve separation is performed with a cutoff size of 500-750 kDa, and the cutoff end product is collected.

[0027] In a fifth aspect, the present invention provides the use of the pretreatment method of cell culture fluid containing extracellular vesicles described in the fourth aspect in separating and purifying extracellular vesicles.

[0028] Compared with the prior art, the present invention has at least the following beneficial effects:

[0029] In the present invention, substances that can promote the disaggregation of macromolecular aggregates in cell culture fluid are explored to facilitate the removal of aggregates. At the same time, a method that can be applied to the separation and purification of extracellular vesicles is further developed. Arginine ethyl ester and / or lipoic acid depolymers are used in the aggregate disaggregation process to open large molecular weight aggregates in the feed liquid, which is helpful for the removal of non-extracellular vesicle products in the feed liquid and improves the purity of the extracellular vesicles. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 The figure shows the effect of removing Agrin protein by disaggregants of different concentrations.

[0031] Figure 2 This is a diagram showing the effect of different concentrations of disaggregates in removing free mIL-12 protein;

[0032] Figure 3 The result graph shows that the addition of different concentrations of disaggregates improves the purity of EVs;

[0033] Figure 4 This is a diagram showing the removal effect of different concentrations of depolymers on DNA in the feed solution;

[0034] Figure 5 This is a graph showing the effect of different added concentrations of lipoic acid on the stability of EVs-nanoLuc. DETAILED DESCRIPTION

[0035] The technical solution of the present invention is further described below in conjunction with the accompanying drawings and through specific implementation methods. However, the following examples are only simplified examples of the present invention and do not represent or limit the scope of protection of the present invention. The scope of protection of the present invention shall be subject to the claims.

[0036] If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in the field or the product instructions are used. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased through regular channels.

[0037] The present invention explores substances that can promote the disaggregation of macromolecular aggregates (such as protein polymers or nucleic acid-protein polymers, etc.) in cell culture fluids. These substances can promote opening and dispersion to form monomers or smaller particles or polymers, which are convenient for separation based on molecular size through tangential flow filtration (TFF) or molecular sieves (exclusion chromatography), etc., to remove these polymers. The present invention has broad application prospects and can be widely used in fields that require separation and removal of macromolecular polymers in cell culture fluids, such as separation and purification of extracellular vesicles from cell culture fluids.

[0038] In the specific embodiment of the present invention, the process of separating and purifying extracellular vesicles from cell culture fluid is taken as an example to verify the technical scheme of the present invention. Specifically, the feed liquid preparation includes: the cell culture supernatant (HEK293F cells expressing mouse IL-12, mIL-12) is centrifuged at 500×g and 4000×g to remove cells and cell debris, and then filtered at 0.45μm and 0.22μm in sequence; the feed liquid is ultrafiltrated and concentrated: about 2L of cell culture supernatant is ultrafiltrated and concentrated by a 750kDa hollow fiber column (Ripligin, S02-E750-05-N), the inlet flow rate is 560mL / min, the permeate flow rate is 40mL / min, and it is concentrated 4 times, and filtered 6 times with phosphate buffered saline (PBS; Solarbio, P1020) as the starting sample; the filtered sample is divided into 50mL portions and frozen at -80°C for use.

[0039] Example 1

[0040] This example tests the removal effect of arginine ethyl ester and lipoic acid on aggregates in cell culture fluid.

[0041] Feed solution depolymerization: Arginine ethyl ester (Adamas, 51988D) or lipoic acid (Leyan, 1017994) was added to the treated cell culture supernatant (prepared in the above feed solution preparation process) at different concentrations, and ATP (Aladdin, A111205) and PBS were added as controls, see Table 1; each reagent was added according to its concentration (fixed to 100 mL), mixed, and placed at 4°C overnight, and then concentrated 2 times to 50 mL using 750kDa TFF (Ripligin, D02-E750-05-N), and then washed and filtered / buffered with PBS. After washing and filtering 10 times, 1.5 mL of the interception end sample was taken for detection of relevant evaluation indicators.

[0042] Table 1 Different molar concentrations of ArgEE and LA for protein aggregate disaggregation

[0043]

[0044]

[0045] Removal effect evaluation:

[0046] Agrin protein removal effect in culture supernatant: Agrin is a large extracellular matrix protein with an amino acid molecular weight of approximately 220 kDa, but due to its high glycosylation modification, the actual molecular weight is between 400 kDa and 600 kDa; the protein interacts with other proteins to form larger protein aggregates or complexes. This protein was used to evaluate the depolymerization effect of ArgEE and LA, and ATP was selected as the control for the added group and PBS as the control for the non-added group. After the feed solution was depolymerized and TFF treated, the Agrin-specific ELISA kit (Abcam, ab216945) was used to detect the content of this protein at the TFF retention end and the feed solution before treatment, and the removal efficiency of Agrin protein was calculated. The removal efficiency calculation formula is: % (removal efficiency) = 1-(total content of Agrin protein at the retention end / total content of Agrin protein in the feed solution before treatment)%. Figure 1 The results show that in the group without adding disaggregants (PBS), the removal efficiency of Agrin protein is only 15%; with the increase of arginine ethyl ester concentration, Agrin protein is greatly removed (removal efficiency from 13%-72%); at the same time, lipoic acid has a better removal effect (removal efficiency from 73%-84%), and the ATP removal effect does not change significantly with the increase of concentration.

[0047] Effect of removing free mIL-12 protein in culture supernatant: IL12 has the effect of activating the body's immune system and anti-tumor. Through genetic engineering, extracellular vesicles (EVs) can be used to carry IL-12 (EVs-IL12) to improve the effect and safety of treatment. In this example, HEK293F cells expressing mouse IL-12 (mIL-12) were used to evaluate the effect of arginine ethyl ester and other depolymers on the removal of free mIL-12 that was not bound to extracellular vesicles (Mouse IL-12p70 precoatedELISA Kit, Dakoway). Figure 2 It can be seen that different concentrations of arginine ethyl ester can remove most of the free mIL-12. When the concentration reaches 1M, the removal efficiency reaches 94% (the calculation method refers to Agrin protein); the control group ATP can also remove some free mIL-12 by increasing the concentration (the highest removal efficiency is 84%), and lipoic acid maintains a stable removal effect. At the same time, the non-depolymerization control group (PBS) also has a removal effect of nearly 67% of free mIL-12, indicating that the use of large-pore TFF (500-750kDa) can remove non-bound target proteins in the feed solution, but a part of the mIL-12 bound to extracellular vesicles or protein aggregates needs to be removed by adding depolymerization products.

[0048] Adding disaggregates improves the purity of extracellular vesicles: By removing non-extracellular vesicle substances, the safety and effectiveness of extracellular vesicles are improved. The number of particles / total protein (particles / BCA-μg) is used to evaluate the purity of extracellular vesicles. The larger the value, the higher the purity of the extracellular vesicles. The particle concentration is detected by nanoFCM (Fuliu Biotechnology), and the total protein concentration is detected by BCA method (Micro BCA TM Protein Assay Kit, Thermo Scientific). Figure 3 The results showed that compared with the control group, the purity of EVs can be improved with the increase of arginine ethyl ester concentration; while the improvement in the ATP group was not obvious, and lipoic acid significantly improved the purity of extracellular vesicles with the increase of concentration. This result shows that the addition of protein disaggregants to the extracellular vesicle-containing feed solution has not only a significant removal effect on the above-mentioned specific proteins (Agrin / free mIL-12), but also has a dispersing and dissociating effect on other potential protein polymers or complexes in the feed solution, turning larger molecular weight polymers into smaller molecular weight monomers or smaller particles, which are convenient for large-pore (500-750kDa) TFF removal.

[0049] The addition of disaggregants enhances the TFF removal effect of nucleic acids in the culture supernatant: in addition to various protein components, the extracellular vesicle feed liquid also contains nucleic acid substances. Some nucleic acid substances are encapsulated in the extracellular vesicles and become inherent components of the extracellular vesicles; some exist in the feed liquid in the form of free or nucleic acid-protein complexes. As impurities that are potential host sources of extracellular vesicles, they need to be removed by adding nucleases or separation and purification processes. The use of nucleases will significantly increase the cost of extracellular vesicle production and preparation. This example compares the removal effect of different disaggregants combined with large-pore TFF (500-750kDa) on total DNA in the feed liquid (ExKubitPlus dsDNA HS Analysis Kit, Icosai) without the addition of nucleases. From Figure 4 The results showed that without adding nuclease, only lipoic acid at various concentrations could remove most of the DNA, with a removal efficiency of 60%. This result shows that lipoic acid has a good dissociation effect on nucleic acid-protein complexes, releasing bound nucleic acids, which are then removed by TFF. Therefore, the use of lipoic acid can significantly reduce the amount of nuclease used in the production process, thereby reducing the cost of large-scale production of extracellular vesicles.

[0050] Depolymerization effect of different molar concentrations of ArgEE and LA: Take the TFF solution packaged above and treat it with the concentration combination in the table below to test the depolymerization effect of the cell supernatant (Table 2).

[0051] Table 2 Depolymerization test of ArgEE and LA at different molar concentration combinations

[0052]

[0053] After adding the above-mentioned disaggregation reagents of different concentrations to the treated cell culture supernatant, mix thoroughly, place on a shaker, incubate overnight at 4°C and 90 rpm for 16 hours. pure 25 (Cytiva) chromatography system, SEC chromatography column (Superdex TM 200Increase 10 / 300GL, Cytiva) for separation and purification: sample volume 0.5mL, flow rate 0.5mL / min; collect exosome peaks, and perform particle concentration (nanoFCM, Fuliu Biotechnology), total protein concentration (Micro BCA TM Protein Assay Kit, Thermo Scientific) was used to measure the purity of extracellular vesicles by the number of particles / total protein (particles / μg). The results are shown in Table 2. The combination of ArgEE and LA can also effectively disaggregate.

[0054] Example 2

[0055] This example tests the effects of different concentrations of lipoic acid on the integrity of the extracellular vesicle membrane.

[0056] It can be seen from the above examples that lipoic acid has a good protein aggregate disaggregation effect and can significantly improve the purity of EVs. In this example, it was further evaluated whether the addition of different concentrations of lipoic acid had an effect on the membrane integrity of the extracellular vesicles. If the lipid membrane of the extracellular vesicle is damaged, it will lead to leakage of the contents: HEK293F-derived extracellular vesicles (EVs-nanoLuc) containing nanoLuciferase were used for testing, and different final concentrations of LA (1mM, 10mM, 20mM, 30mM, 100mM) were added to the extracellular vesicles, placed on a room temperature shaker with a speed of 100rpm, and samples were taken at 4h and 24h for luciferase activity determination. During the determination, proteinase K treatment and non-treatment were performed to evaluate whether there was luciferase leakage. From Figure 5 The results show that when the concentration of lipoic acid reaches 30mM, the fluorescence signal shows a downward trend at both 4h and 24h detection points, indicating that under this concentration condition, the membrane integrity of EVs may be affected.

[0057] Therefore, combined with the results of the above examples, considering the properties of different source solutions, purification purposes and cost considerations, the preferred concentration range of lipoic acid is 10mM to 30mM; while ArgEE has no effect on EVs under high concentration conditions, and the preferred concentration range is 0.25M to 1M.

[0058] In summary, the present invention explores substances that can promote the aggregation of macromolecules in cell culture fluid, and finds that arginine ethyl ester and / or lipoic acid can effectively promote the disaggregation of aggregates, which is convenient for separation based on molecular size by tangential flow ultrafiltration or molecular sieve (exclusion chromatography), etc., to remove these polymers. The present invention has broad application prospects and can be widely used in fields that require separation and removal of macromolecular polymers in cell culture fluid, such as separation and purification of extracellular vesicles from cell culture fluid.

[0059] The applicant declares that the above is only a specific implementation mode of the present invention, but the protection scope of the present invention is not limited thereto. Those skilled in the art should understand that any changes or substitutions that can be easily thought of by those skilled in the art within the technical scope disclosed by the present invention shall fall within the protection scope and disclosure scope of the present invention.

Claims

1. Use of arginine ethyl ester, its salt or solvent compound, and / or lipoic acid, its salt or solvent compound in promoting the disaggregation of aggregates in cell culture fluid.

2. The use according to claim 1, characterized in that: The aggregates include protein and / or nucleic acid aggregates; Preferably, the cell culture fluid comprises a cell culture fluid containing extracellular vesicles.

3. Use of arginine ethyl ester, its salt or solvent compound, and / or lipoic acid, its salt or solvent compound in the preparation of an agent for promoting the disaggregation of aggregates in a cell culture medium.

4. A kit for promoting the disaggregation of aggregates in cell culture fluid, characterized in that: The kit contains arginine ethyl ester, its salt or solvent compound, and / or lipoic acid, its salt or solvent compound.

5. A method for pretreating a cell culture fluid containing extracellular vesicles, characterized in that: The pretreatment method comprises: Arginine ethyl ester, its salt or solvent compound, and / or lipoic acid, its salt or solvent compound are added to the cell culture fluid containing the extracellular vesicles for separation.

6. The method for pretreating a cell culture fluid containing extracellular vesicles according to claim 5, characterized in that: The working concentration of the arginine ethyl ester, its salt or solvent compound is 0.1 to 2 mol / L, preferably 0.25 to 1 mol / L; Preferably, the working concentration of lipoic acid, its salt or solvent compound is 1 to 50 mmol / L, preferably 10 to 30 mmol / L.

7. The method for pretreating a cell culture fluid containing extracellular vesicles according to claim 5 or 6, characterized in that: The separation method includes ultrafiltration or molecular sieve separation; Preferably, the ultrafiltration comprises tangential flow ultrafiltration.

8. The method for pretreating a cell culture fluid containing extracellular vesicles according to claim 7, characterized in that: The separation cut-off size is greater than 300 kDa, preferably 500-750 kDa.

9. The method for pretreating a cell culture fluid containing extracellular vesicles according to any one of claims 5 to 8, characterized in that: The pretreatment method comprises: 0.1-2 mol / L of arginine ethyl ester, its salt or solvent compound, and / or 1-50 mmol / L of lipoic acid, its salt or solvent compound are added to the cell culture fluid containing extracellular vesicles, and tangential flow ultrafiltration or molecular sieve separation is performed with a cutoff size of 500-750 kDa, and the cutoff end product is collected.

10. Use of the pretreatment method of cell culture fluid containing extracellular vesicles according to any one of claims 5 to 9 in isolating and purifying extracellular vesicles.